Voyager Therapeutics, Inc.
- VYGR
- NASDAQ
- Biotechnology
- Gene Therapy (AAV)
- Neurology/Parkinson's
- Clinical-Stage Biotech
$1.90
Today −7.77%Quote Oct 16, 2026, 08:00 PM UTC
−37.50%over the last month
Max drawdown −39.5%From 1-month high −39.5%3 months −37.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$117.1M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$14.40
+657.9% from here
Floor
—
Data unavailable
Where the price sits
21 analysts
Analyst range, low to high
$8.00$18.00
- Price $1.90
- Resistance $2.12
- Consensus $14.40
Analysts' average target sits about 658% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VYGRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
141
Founded
2013